Review Article
Dental Stem Cell-Derived Secretome/Conditioned Medium: The Future for Regenerative Therapeutic Applications
Table 3
Summary of the included studies investigating the effect of dental MSCs’ secretome/conditioned medium on dental and periodontal tissue regeneration.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
BDNF: brain-derived neurotrophic factor; BMP: bone morphogenetic protein; CM: conditioned medium; COX-2: cyclooxygenase-2; CXCL14: chemokine (C-X-C motif) ligand 14; DSPP: dentin sialophosphoprotein; EXs: exosomes; FGF: fibroblast growth factor; G-CSF: granulocyte colony-stimulating factor; GM-CSF: granulocyte-macrophage colony-stimulating factor; HUVECs: human umbilical vascular endothelial cells; IGFBP: insulin-like growth factor-binding protein; IL: interleukin; MCP-1: monocyte chemoattractant protein-1; MMP: matrix metalloproteinase; mRNA: messenger RNA; MSCs: mesenchymal stem cells; NPY: neuropeptide Y; PAI-1: plasminogen activator inhibitor-1; PDGF: platelet-derived growth factor; PLAP-1: periodontal ligament-associated protein 1; RUNX2: runt-related transcription factor 2; Serpin E1: serine protease inhibitor E1; SHED: stem cells derived from human exfoliated deciduous teeth; TGF-β: transforming growth factor-β; TIMP-1: tissue inhibitor of metalloproteinase-1; TNF-α: tumor necrosis factor alpha; TRH-DE: thyrotropin-releasing hormone degrading enzyme; uPA: urokinase plasminogen activator; VEGF: vascular endothelial growth factor. |